Your Daily Pharma Scoop: Secondaries Review June 4-11

Your Daily Pharma Scoop: Secondaries Review June 4-11

A discussion of secondary offerings provides interesting analysis of a company. There are two kinds of secondary offerings; one, the non-dilutive kind, where no new shares are issued, but a large institutional shareholder simply releases a large block of previously issued shares. Two, a dilutive secondary, where the company itself issues new shares in order […]

Mass. Attorney General Maura Healey sues opioid maker Purdue Pharma

Mass. Attorney General Maura Healey sues opioid maker Purdue Pharma

Attorney General Maura Healey is suing Purdue Pharma, the maker of powerful opioids like OxyContin, alleging the company misled doctors and consumers about their risks with the aim of getting more people to take them at higher doses for longer periods of time — in order to boost the company’s bottom line. Opening a new […]

FDA: Ripley's Delta Pharma ordered to stop operations

FDA: Ripley's Delta Pharma ordered to stop operations

Scroll for more content… RIPLEY, Miss. (WTVA) – A Ripley-based compounding pharmacy is prohibited from manufacturing and distributing drugs after an injunction was entered last week.  U.S. District Judge Neal Biggers for the Northern District of Mississippi entered a consent decree of permanent injunction last week between the United States and Delta Pharma, Inc. of Ripley, as […]

Five things for pharma marketers to know: Tuesday, June 12, 2018

Five things for pharma marketers to know: Tuesday, June 12, 2018

Copyright © 2018 Haymarket Media, Inc. All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions. Source link

Alexion-Complement Pharma Tie Up to Treat Neuro Disorders

Alexion-Complement Pharma Tie Up to Treat Neuro Disorders

Alexion Pharmaceuticals, Inc. (ALXN – Free Report) announced a partnership with Complement Pharma to co-develop the preclinical C6 complement inhibitor, CP010, for neurodegenerative disorders. CP010 is a humanized monoclonal antibody in preclinical stages that binds to C6 in circulation to inhibit its function throughout the body by preventing MAC formation in both the periphery and […]

Andriukaitis: SPC manufacturing waiver does not damage pharma innovation

Andriukaitis: SPC manufacturing waiver does not damage pharma innovation

The European Commission’s proposal to add an SPC manufacturing waiver on exports will not damage innovation, as the pharma industry claims, and only intends to support small and medium generic drug companies, according to EU Health Commissioner Vytenis Andriukaitis. “I understand those messages but this is not about reality,” Andriukaitis told EURACTIV.com, referring to the […]

Orchid Pharma locked in 5% upper circuit post EU GMP certification

Orchid Pharma locked in 5% upper circuit post EU GMP certification

Shares of Orchid Pharma were locked in 5 percent upper circuit on Tuesday morning as investors cheered a positive regulatory development. The company received EU GMP (Good Manufacturing Practice) certification based on the inspection of the Orchid’s APl manufacturing facility located at SlDCO Industrial Estate, Alathur, Kancheepuram District, it told the exchanges. The facility was […]